Bone morphogenetic proteins as regulators of iron metabolism

Annual Review of Nutrition

Volumn 34, Issue , 2014, Pages 77-94

  Parrow, Nermi L ^a   Fleming, Robert E ^b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone morphogenic proteins; Hepcidin; Hereditary hemochromatosis; Iron homeostasis

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HEMOJUVELIN; HEPCIDIN; IRON; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; IRON INTAKE;

ARTICLE; CELL DIFFERENTIATION; COMPLICATION; EMBRYO DEVELOPMENT; GENE MUTATION; HEMOCHROMATOSIS; HOMEOSTASIS; HUMAN; IRON DEFICIENCY ANEMIA; IRON METABOLISM; IRON STORAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; GENETICS; INTESTINE ABSORPTION; INTESTINE MUCOSA; IRON INTAKE; LIVER; METABOLISM; MUTATION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; HEMOCHROMATOSIS; HOMEOSTASIS; HUMANS; INTESTINAL ABSORPTION; INTESTINAL MUCOSA; IRON, DIETARY; LIVER; MODELS, BIOLOGICAL; MUTATION; SIGNAL TRANSDUCTION;

EID: 84904666636     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071813-105646     Document Type: Article

References (76)

1. Anderson GJ 2009. Things that go BMP in the liver: bone morphogenetic protein 6 and the control of body iron homeostasis. Hepatology 50:316-19
2. Anderson GJ, Vulpe CD. 2009. Mammalian iron transport. Cell. Mol. Life Sci. 66:3241-61
3. Andrews NC, Schmidt PJ. 2007. Iron homeostasis. Annu. Rev. Physiol. 69:69-85
4. Andriopoulos B, Corradini E, Xia Y, Faasse SA, Chen SZ, et al. 2009. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 41:482-87
5. Arndt S,Maegdefrau U, Dorn C, SchardtK,Hellerbrand C, BosserhoffAK. 2010. Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo. Gastroenterology 138:372-82
6. Babitt JL, Huang FW,Wrighting DM, Xia Y, Sidis Y, et al. 2006. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38:531-39
7. Babitt JL, Huang FW, Xia Y, Sidis Y, Andrews NC, Lin HY. 2007. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J. Clin. Invest. 117:1933-39
8. Babitt JL, Lin HY. 2011. The molecular pathogenesis of hereditary hemochromatosis. Semin. Liver Dis. 31:280-92
9. Balemans W, Vanhul W. 2002. Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. 250:231-50
10. BartnikasTB, AndrewsNC, FlemingMD. 2011. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. Blood 117:630-37
11. Bayele HK, Srai SK. 2009. Genetic variation in hepcidin expression and its implications for phenotypic differences in iron metabolism. Haematologica 94:1185-88
12. Camaschella C. 2009. BMP6 orchestrates iron metabolism. Nat. Genet. 41:386-88
13. Camaschella C, Poggiali E. 2011. Inherited disorders of iron metabolism. Curr. Opin. Pediatr. 23:14-20
14. Castoldi M, Vujic Spasic M, Altamura S, Elmen J, Lindow M, et al. 2011. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J. Clin. Invest. 121:1386-96
15. Chang C,Holtzman DA, Chau S, ChickeringT,Woolf EA, et al. 2001. Twisted gastrulation can function as a BMP antagonist. Nature 410:483-87
16. Chua AC, Trinder D, Olynyk JK. 2011. Liver and serum iron: discrete regulators of hepatic hepcidin expression. Hepatology 54:16-19
17. Chung B, Verdier F, Matak P, Deschemin JC, Mayeux P, Vaulont S. 2010. Oncostatin M is a potent inducer of hepcidin, the iron regulatory hormone. FASEB J. 24:2093-103
18. Corradini E, Garuti C, Montosi G, Ventura P, Andriopoulos B, et al. 2009. Bone morphogenetic protein signaling is impaired in an Hfe knockout mouse model of hemochromatosis. Gastroenterology 137:1489-97
19. Corradini E, Meynard D,WuQ, Chen S, Ventura P, et al. 2011. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice. Hepatology 54:273-84
20. Corradini E, Rozier M, Meynard D, Odhiambo A, Lin HY, et al. 2011. Iron regulation of hepcidin despite attenuated Smad1,5,8 signaling in mice without transferrin receptor 2 or Hfe. Gastroenterology 141:1907-14
21. Corradini E, Schmidt PJ, MeynardD,GarutiC,Montosi G, et al. 2010. BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. Gastroenterology 139:1721-29
22. De Domenico I, McVeyWardD,Kaplan J. 2008. Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat. Rev. Mol. Cell Biol. 9:72-81
23. Enns CA, Ahmed R, Wang J, Ueno A, Worthen C, et al. 2013. Increased iron loading induces Bmp6 expression in the non-parenchymal cells of the liver independent of the BMP-signaling pathway. PLoS ONE 8:e60534
24. Enns CA, Ahmed R, Zhang AS. 2012. Neogenin interacts with matriptase-2 to facilitate hemojuvelin cleavage. J. Biol. Chem. 287:35104-17
25. Feng Q, MigasMC, Waheed A, Britton RS, Fleming RE. 2012. Ferritin upregulates hepatic expression of bonemorphogenetic protein 6 and hepcidin in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 302:G1397- 404
26. Finberg KE. 2009. Iron-refractory iron deficiency anemia. Semin. Hematol. 46:378-86
27. Fleming RE, Feng Q, Britton RS. 2011. Knockout mouse models of iron homeostasis. Annu. Rev. Nutr. 31:117-37
28. Folgueras AR, de Lara FM, Pendas AM, Garabaya C, Rodriguez F, et al. 2008. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. Blood 112:2539-45
29. Gamer LW, Nove J, Levin M, Rosen V. 2005. BMP-3 is a novel inhibitor of both activin and BMP-4 signaling in Xenopus embryos. Dev. Biol. 285:156-68
30. Ganz T. 2011. Hepcidin and iron regulation, 10 years later. Blood 117:4425-33
31. Ganz T, Nemeth E. 2011. Hepcidin and disorders of iron metabolism. Annu. Rev. Med. 62:347-60
32. Hentze MW,MuckenthalerMU, Galy B, Camaschella C. 2010. Two to tango: regulation of mammalian iron metabolism. Cell 142:24-38
33. Huang XX, McCaughan GW, Shackel NA, Gorrell MD. 2007. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis. Liver Int. 27:960-68
34. Island ML, Jouanolle AM, Mosser A, Deugnier Y, David V, et al. 2009. A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis. Haematologica 94:720-24
35. Kautz L, Meynard D, Besson-Fournier C, Darnaud V, Al Saati T, et al. 2009. BMP/Smad signaling is not enhanced in Hfe-deficient mice despite increased Bmp6 expression. Blood 114:2515-20
36. Kautz L, Meynard D, Monnier A, Darnaud V, Bouvet R, et al. 2008. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 112:1503-9
37. Kew MC. 2009. Hepatic iron overload and hepatocellular carcinoma. Cancer Lett. 286:38-43
38. Knittel T, Fellmer P, Muller L, Ramadori G. 1997. Bone morphogenetic protein-6 is expressed in nonparenchymal liver cells and upregulated by transforming growth factor-beta 1. Exp. Cell Res. 232:263-69
39. Knuesel M,Wan Y, Xiao Z, Holinger E, Lowe N, et al. 2003. Identification of novel protein-protein interactions using a versatile mammalian tandem affinity purification expression system. Mol. Cell Proteomics 2:1225-33
40. Lee P. 2009. Role of matriptase-2 (TMPRSS6) in iron metabolism. Acta Haematol. 122:87-96
41. Li Z, HassanMQ, Jafferji M, Aqeilan RI,GarzonR, et al. 2009. Biological functions ofmiR-29b contribute to positive regulation of osteoblast differentiation. J. Biol. Chem. 284:15676-84
42. Lin L, Goldberg YP, Ganz T. 2005. Competitive regulation of hepcidin mRNA by soluble and cellassociated hemojuvelin. Blood 106:2884-89
43. Lin L, Valore EV, Nemeth E, Goodnough JB, Gabayan V, Ganz T. 2007. Iron transferrin regulates hepcidin synthesis in primary hepatocyte culture through hemojuvelin and BMP2/4. Blood 110:2182-89
44. Massague J, Gomis RR. 2006. The logic of TGF?signaling. FEBS Lett. 580:2811-20
45. Massague J, Seoane J,Wotton D. 2005. Smad transcription factors. Genes Dev. 19:2783-810
46. Maxson JE, Chen J, Enns CA, Zhang AS. 2010. Matriptase-2- and proprotein convertase-cleaved forms of hemojuvelin have different roles in the down-regulation of hepcidin expression. J. Biol. Chem. 285:39021-28
47. Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. 2009. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat. Genet. 41:478-81
48. Meynard D, Vaja V, Sun CC, Corradini E, Chen S, et al. 2011. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. Blood 118:747-56
49. Mleczko-Sanecka K, Casanovas G, Ragab A, Breitkopf K, Muller A, et al. 2010. SMAD7 controls iron metabolism as a potent inhibitor of hepcidin expression. Blood 115:2657-65
50. Nai A, Pagani A, Mandelli G, Lidonnici MR, Silvestri L, et al. 2012. Deletion of Tmprss6 attenuates the phenotype in a mouse model of ?-thalassemia. Blood 119:5021-29
51. Nemeth E. 2008. Iron regulation and erythropoiesis. Curr. Opin. Hematol. 15:169-75
52. Nemeth E, TuttleMS, Powelson J, VaughnMB, Donovan A, et al. 2004. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306:2090-93
53. Nili M, Shinde U, Rotwein P. 2010. Soluble repulsive guidance molecule c/hemojuvelin is a broad spectrum bone morphogenetic protein (BMP) antagonist and inhibits both BMP2- and BMP6-mediated signaling and gene expression. J. Biol. Chem. 285:24783-92
54. Parrow NL, Gardenghi S, Ramos P, Casu C, Grady RW, et al. 2012. Decreased hepcidin expression in murine ?-thalassemia is associated with suppression of Bmp/Smad signaling. Blood 119:3187-89
55. Patel N, Masaratana P, Diaz-Castro J, Latunde-Dada GO, Qureshi A, et al. 2012. BMPER protein is a negative regulator of hepcidin and is up-regulated in hypotransferrinemic mice. J. Biol. Chem. 287:4099-106
56. Ramos E, Kautz L, Rodriguez R, Hansen M, Gabayan V, et al. 2011. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 53:1333-41
57. Ramos P, Guy E, Chen N, Proenca CC, Gardenghi S, et al. 2011. Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis. Blood 117:1379-89
58. Ramsay AJ, Hooper JD, Folgueras AR, Velasco G, L opez-Otin C. 2009. Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis. Haematologica 94:840-49
59. Ryan JD, Ryan E, Fabre A, Lawless MW, Crowe J. 2010. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis. Hepatology 52:1266-73
60. Schmierer B, Hill CS. 2007. TGF?-SMAD signal transduction: molecular specificity and functional flexibility. Nat. Rev. Mol. Cell Biol. 8:970-82
61. Sheftel AD, Mason AB, Ponka P. 2011. The long history of iron in theUniverse and in health and disease. Biochim. Biophys. Acta 1820:161-87
62. Silvestri L, Pagani A, Nai A, De Domenico I, Kaplan J, Camaschella C. 2008. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metab. 8:502-11
63. Steinbicker AU, Sachidanandan C, Vonner AJ, Yusuf RZ, Deng DY, et al. 2011. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood 117:4915-23
64. Tanaka C, Sakuma R, Nakamura T, Hamada H, Saijoh Y. 2007. Long-range action of Nodal requires interaction with GDF1. Genes Dev. 21:3272-82
65. Tanno T, Porayette P, Sripichai O, Noh SJ, Byrnes C, et al. 2009. Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood 114:181-86
66. Truksa J, Lee P, Beutler E. 2009. Two BMPresponsive elements, STAT, and bZIP/HNF4/COUP motifs of the hepcidin promoter are critical for BMP, SMAD1, and HJV responsiveness. Blood 113:688-95
67. Truksa J, Lee P, Peng H, Flanagan J, Beutler E. 2007. The distal location of the iron responsive region of the hepcidin promoter. Blood 110:3436-37
68. Voskaridou E, Terpos E. 2004. New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia. Br. J. Haematol. 127:127-39
69. Wallace DF, Summerville L, Crampton EM, Frazer DM, Anderson GJ, Subramaniam VN. 2009. Combined deletion of Hfe and transferrin receptor 2 in mice leads to marked dysregulation of hepcidin and iron overload. Hepatology 50:1992-2000
70. Wang RH, Li C, Xu X, Zheng Y, Xiao C, et al. 2005. A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metab. 2:399-409
71. Xia Y, Babitt JL, Sidis Y, Chung RT, Lin HY. 2008. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 111:5195-204
72. Xiao YT,XiangLX, Shao JZ. 2007. Bone morphogenetic protein. Biochem. Biophys. Res. Commun. 362:550-53
73. Zhang AS. 2010. Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis. Adv. Nutr. 1:38-45
74. Zhang AS, Gao J, Koeberl DD, Enns CA. 2010. The role of hepatocyte hemojuvelin in the regulation of bone morphogenic protein-6 and hepcidin expression in vivo. J. Biol. Chem. 285:16416-23
75. Zhang Z, Guo X, Herrera C, Tao Y,Wu Q, et al. 2014. Bmp6 expression can be regulated independently of liver iron in mice. PLoS ONE 9:e84906
76. Zhu F, Friedman MS, Luo W, Woolf P, Hankenson KD. 2012. The transcription factor osterix (SP7) regulates BMP6-induced human osteoblast differentiation. J. Cell Physiol. 227:2677-85